TrialJAMA neurology2020

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.

Alette M Wessels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.